OBJECTIVE: The aim of this study was to investigate outcomes of child psychiatric outpatient treatment as usual and to identify outcome predictors, with special regard to attention-deficit/hyperactivity disorder (ADHD), mood disorder, obsessive-compulsive disorder and conduct disorder. METHOD: Routinely collected data from 12 613 outpatients between July 2006 and January 2010 in Stockholm, Sweden were analysed. The outcome measure was change in Children's Global Assessment Scale (CGAS) ratings between first visit and case closure (∆CGAS). RESULTS: CGAS improved during the course of treatment across all diagnostic groups, ranging from a mean change of 4 (mental retardation) to 16 (suicide attempts). ∆CGAS was two times higher in the mood disorder group compared with the ADHD group. In the mood disorder group, several psychotherapies were associated with better outcome but not medication. In the ADHD group, psychotherapeutic interventions were also associated with better outcome, but those who received treatment with central stimulants received less non-medical interventions. CONCLUSION: Whereas the functional impairment and the level of improvement in mood disorder corresponded to previous efficacy studies, the ADHD patients were more impaired and improved less after treatment. This should prompt a critical discussion as to whether ADHD patients receive the best available treatment in CAMHS in Stockholm and elsewhere.
OBJECTIVE: The aim of this study was to investigate outcomes of childpsychiatricoutpatient treatment as usual and to identify outcome predictors, with special regard to attention-deficit/hyperactivity disorder (ADHD), mood disorder, obsessive-compulsive disorder and conduct disorder. METHOD: Routinely collected data from 12 613 outpatients between July 2006 and January 2010 in Stockholm, Sweden were analysed. The outcome measure was change in Children's Global Assessment Scale (CGAS) ratings between first visit and case closure (∆CGAS). RESULTS: CGAS improved during the course of treatment across all diagnostic groups, ranging from a mean change of 4 (mental retardation) to 16 (suicide attempts). ∆CGAS was two times higher in the mood disorder group compared with the ADHD group. In the mood disorder group, several psychotherapies were associated with better outcome but not medication. In the ADHD group, psychotherapeutic interventions were also associated with better outcome, but those who received treatment with central stimulants received less non-medical interventions. CONCLUSION: Whereas the functional impairment and the level of improvement in mood disorder corresponded to previous efficacy studies, the ADHDpatients were more impaired and improved less after treatment. This should prompt a critical discussion as to whether ADHDpatients receive the best available treatment in CAMHS in Stockholm and elsewhere.
Authors: Sebastian Lundström; Mats Forsman; Henrik Larsson; Nora Kerekes; Eva Serlachius; Niklas Långström; Paul Lichtenstein Journal: J Autism Dev Disord Date: 2014-11
Authors: Agnieszka Butwicka; Niklas Långström; Henrik Larsson; Sebastian Lundström; Eva Serlachius; Catarina Almqvist; Louise Frisén; Paul Lichtenstein Journal: J Autism Dev Disord Date: 2017-01
Authors: S L Roest; B M Siebelink; H van Ewijk; R R J M Vermeiren; C M Middeldorp; R M van der Lans Journal: Epidemiol Psychiatr Sci Date: 2021-11-23 Impact factor: 7.818
Authors: Martin Cederlöf; Henrik Larsson; Paul Lichtenstein; Catarina Almqvist; Eva Serlachius; Jonas F Ludvigsson Journal: BMC Psychiatry Date: 2016-07-04 Impact factor: 3.630